Expert Review of Neurotherapeutics

Does gender play a role in Alzheimer therapy?
pp. 589-591(3)
Author: Heun, Reinhard

News in Brief
pp. 592-600(9)

Amantadine treatment for cocaine-dependent patients with severe withdrawal symptoms
pp. 601-608(8)
Author: Kampman, Kyle M

Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicin
pp. 609-615(7)
Authors: Hau, Peter; Dietrich, Joerg; Fabel, Klaus; Bogdahn, Ulrich

Nefazodone in the treatment of patients with post-traumatic stress disorder
pp. 617-623(7)
Authors: Sharpe, Rachel H; Voris, John C

Oral transmucosal fentanyl citrate: a novel agent for breakthrough pain related to cancer
pp. 625-629(5)
Authors: McMenamin, Erin; Farrar, John T

Intrathecal steroid therapy for postherpetic neuralgia: a review
pp. 631-637(7)
Authors: Nelson, Dewey A; Landau, William M

Genomics of immune molecules: early detection of cognitive decline and new therapeutic interventions
pp. 639-645(7)
Author: Licastro, Federico

Acetyl-l-carnitine as a possible therapy for Alzheimer’s disease
pp. 647-654(8)
Authors: Pettegrew, Jay W; McClure, Richard J

Pharmacotherapy of agitation and psychotic symptoms in Alzheimer’s disease
pp. 655-664(10)
Author: Verhoeff, Nicolaas PLG

Neurosyphilis: is it still a clinically relevant form of dementia?
pp. 665-668(4)
Authors: Thompson, Matthew M; Samuels, Steven C

Bristol Activities of Daily Living Scale: a critical evaluation
pp. 669-676(8)
Authors: Bucks, Romola S; Haworth, Judy

Transcriptional mechanisms underlying neuropathic pain: DREAM, transcription factors and future pain management?
pp. 677-689(13)
Authors: Cheng, Hai-Ying M; Penninger, Josef M

New pharmacological strategies for pain relief
pp. 691-702(12)
Authors: Gillen, Clemens; Maul, Corinna

Therapeutic options in neurosarcoidosis
pp. 703-708(6)
Authors: Kaliszky, Zoltan; Walker, Aljoeson; Tyor, William R

Neurobehavioral and psychological changes induced by hyperthyroidism: diagnostic and therapeutic implications
pp. 709-716(8)
Authors: Fardella, Carlos E; Gloger, Sergio

Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder
pp. 717-724(8)
Authors: Baldwin, David; Buis, Christel; Mayers, Andrew

Phenomenology and therapeutic options for dermatotillomania
pp. 725-730(6)
Author: Arnold, Lesley M

Cognitive dysfunction in multiple sclerosis: current approaches to clinical management
pp. 731-742(12)
Authors: Amato, Maria Pia; Zipoli, Valentina

Treatment of myasthenia gravis: current practice and future directions
pp. 743-748(6)
Authors: Ciafaloni, Emma; Sanders, Donald B

Behavioral treatment strategies for migraine and tension-type headache: a review of the evidence and future directions
pp. 749-760(12)
Authors: Rains, Jeanetta C; Penzien, Donald B